1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)-cyclopropanecarboxylic acid, 95.0%, 100g

5-bromo-4-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid, 95.0%, 100mg

4,5-Dihydroxynaphthalene-2,7-disulfonic acid, 95.0%, 25g

Mubritinib>98.0%(HPLC)25mg

5-Bromo-1-methyl-1H-imidazole-2-carboxaldehyde, 95.0%, 250mg

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 1 ml, 100–500 dalton(s), 12 Piece(s)

6-Chloro-2-methyl-1H-pyrrolo[3,2-c]pyridine, 97%, 500mg

(5E)-2-mercapto-5-(1-naphthylmethylene)-1,3-thiazol-4(5H)-one, 95.0%, 1g

4-Phenylphenol, 95.0%, 25g

tert-Butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate, 95.0%, 250mg

7-chloro-2,3,4-trimethyl-1,8-naphthyridine, 95.0%, 250mg

(R)-5-Benzyl-2-(2,4,6-trichlorophenyl)-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate, 97%, 100mg

1-(Prop-2-ynyl)urea, 95.0%, 5g